Orthocell September Quarter Investor Webinar

Orthocell's CEO, CFO and commercial chief on the September 2026 quarter, the US rollout of the Remplir nerve repair product and strategic priorities.

When

Thursday 22 October, 11 am AEDT

10 am Brisbane · 10:30 am Adelaide · 8 am Perth · 1 hr

What you’ll learn

Results for the quarter ended 30 September 2026
Progress on the US rollout of Remplir
Commercial and strategic priorities

Speakers

Paul Anderson

CEO and Managing Director, Orthocell

Jim Piper

Chief Financial Officer, Orthocell

Adam Wood

Chief Commercial Officer, Orthocell

Hosted by

Orthocell

Orthocell Ltd is a Perth-based regenerative medicine company listed on the ASX (OCC). It develops and sells Remplir, a collagen wrap for peripheral nerve repair, and is rolling it out in the United States. Its quarterly investor webinars, held with each quarterly report, have its CEO, CFO and commercial chief take shareholders and interested investors through results, the US launch and strategy, with questions.

Website →